Found: 15
Select item for more details and to access through your institution.
Cost-effectiveness and Budget Effect Analysis of a Population-Based Skin Cancer Screening.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12806-0
- By:
- Publication type:
- Article
Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.789473
- By:
- Publication type:
- Article
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2589, doi. 10.1007/s00262-020-02618-4
- By:
- Publication type:
- Article
Mental Health and Quality of Life among Patients with Cancer during the SARS-CoV-2 Pandemic: Results from the Longitudinal ONCOVID Survey Study.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1093, doi. 10.3390/cancers14041093
- By:
- Publication type:
- Article
Immune Monitoring in Melanoma and Urothelial Cancer Patients Treated with Anti-PD-1 Immunotherapy and SBRT Discloses Tumor Specific Immune Signatures.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2630, doi. 10.3390/cancers13112630
- By:
- Publication type:
- Article
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 2, p. 290, doi. 10.1007/s00259-012-2280-z
- By:
- Publication type:
- Article
Serum tumor markers and PET/CT imaging for tumor recurrence detection.
- Published in:
- Annals of Nuclear Medicine, 2013, v. 27, n. 2, p. 97, doi. 10.1007/s12149-012-0664-6
- By:
- Publication type:
- Article
Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports.
- Published in:
- Endocrine (1355008X), 2014, v. 47, n. 3, p. 878, doi. 10.1007/s12020-014-0199-9
- By:
- Publication type:
- Article
Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-05047-1
- By:
- Publication type:
- Article
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 1, p. 47, doi. 10.1007/s11523-020-00767-1
- By:
- Publication type:
- Article
Throughput efficiency and service quality after process redesign at a cancer day care unit: Two sides of the coin?
- Published in:
- European Journal of Cancer Care, 2019, v. 28, n. 1, p. N.PAG, doi. 10.1111/ecc.12918
- By:
- Publication type:
- Article